Impact of treatment modality, biochemical parameters and apoptosis on polymorphonuclear cell (PMN) function in patients with renal failure

Table

	Controls	CRF	HD	CAPD	P ^*
Apoptosis, %	9.0 ± 5.6	19.8 ± 16.8^†	13.6 ± 9.3	6.4 ± 4.0	0.01
Phagocytosis, %	83.8 ± 7.5	79.2 ± 16.9	49.9 ± 28^‡	86.4 ± 7.1	<0.0001
H₂O₂ release, MFI
SA-stimulated	357 ± 123.4	357.6 ± 30.6	90 ± 41.7^‡	570.4 ± 41.5	0.012
LPS-stimulated	44.6 ± 16.4	50.9 ± 30.0	48.5 ± 27.2	56.4 ± 33.1	0.77
PMA-stimulated	110.6 ± 81.6	95.9 ± 93	37.7 ± 25^‡	152.9 ± 79.6	0.023
fMLP-stimulated	131.9 ± 75.7	72.9 ± 55.5	41.2 ± 16.4^‡	189.2 ± 141.1	<0.001

MFI, mean fluorescence intensity. ^*ANOVA; ^†P < 0.05 versus controls and CAPD; ^‡P < 0.05 versus other groups.

ISSN: 1364-8535